Federal Register - August 19, 2021
Versione di testo Cosa è?Dateas è un sito indipendente non affiliato a entità governative. La fonte dei documenti PDF che pubblichiamo qui è l'entità governativa indicata in ciascuno di essi. Le versioni in testo sono trascrizioni che realizziamo per facilitare l'accesso e la ricerca di informazioni, ma possono contenere errori o non essere complete.
Source: Federal Register
46708
Federal Register / Vol. 86, No. 158 / Thursday, August 19, 2021 / Notices
Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website http videocast.nih.gov.
Name of Committee: National Cancer Institute Clinical Trials and Translational Research Advisory Committee.
Date: November 10, 2021.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: Strategic Discussion of NCIs Clinical and Translational Research Programs.
Place: National Cancer Institute, 9609
Medical Center Drive, Rockville, MD 20850
Virtual Meeting.
Contact Person: Sheila A. Prindiville, M.D., M.P.H., Director, Coordinating Center for Clinical Trials, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 6W136, Rockville, MD
20850, 2402766173, prindivs@
mail.nih.gov.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
Information is also available on the Institutes/Centers home page: http
deainfo.nci.nih.gov/advisory/ctac/ctac.htm, where an agenda and any additional information for the meeting will be posted when available.
Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS
Dated: August 16, 2021.
Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202117821 Filed 81821; 8:45 am BILLING CODE 414001P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
National Institute of Environmental Health Sciences; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Advisory Environmental Health Sciences Council, September 13, 2021, 11:00 a.m. to September 14, 2021, 04:45 p.m., National Institute of Environmental Health Science, Durham, NC 27709
which was published in the Federal Register on August 16, 2021, FR Doc 202117410, 86 FR 45742.
VerDate Sep<11>2014
17:28 Aug 18, 2021
Jkt 253001
This notice is being amended to change the meeting date from September 1314, 2021 to September 13, 2021. The start time for open session is also amended and will now start at 11:45 a.m. and adjourn at 5:15 p.m. The meeting is partially closed to the public.
Dated: August 16, 2021.
David Freeman, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202117819 Filed 81821; 8:45 am BILLING CODE 414001P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis Panel; SEP5: NCI
Clinical and Translational Cancer Research.
Date: October 67, 2021.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W248, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Shree Ram Singh, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W248, Rockville, Maryland 20850, 2406726175, singhshr@
mail.nih.gov.
Name of Committee: National Cancer Institute Initial Review Group; Career Development Study Section J.
Date: October 1213, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W624, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, Resources &
Training Review Branch, Division of
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W624, Rockville, Maryland 20850, 2402766132, tushar.deb@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel;
Strengthening Institutional Capacity to Conduct Global Cancer Research in Lowand Middle-Income Countries.
Date: October 12, 2021.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W248, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Shree Ram Singh, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W248, Rockville, Maryland 20850, 2406726175, singhshr@
mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; NCI
Review of Informatics Technology in Cancer Research.
Date: October 1415, 2021.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W640, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Saejeong J. Kim, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W640, Rockville, Maryland 20850, 2402767684, saejeong.kim@nih.gov.
Name of Committee: National Cancer Institute Initial Review Group; Institutional Training and Education Study Section F.
Date: October 1819, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W234, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Adriana Stoica, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, 7W234, Rockville, Maryland 20850, 240
2766368, Stoicaa2@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis Panel; Centers on Telehealth Research for Cancer-Related Care P50 Clinical Trial Required.
Date: October 2021, 2021.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical Center Drive, Room 7W108, Rockville, Maryland 20850
Telephone Conference Call.
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific Review Officer, Special
E:FRFM19AUN1.SGM
19AUN1
